Price To Earnings Ratio 12.73 | Sector PE 69.14 |
PB Ratio 1.56 | Sector PB 9.25 |
EPS 10.46 | Dividend Yield 2.87 |
Today's Volume 1.020 M | 5 Day Avg. Volume 636.798 K |
PEG Ratio 0.31 | Market Cap. ₹ 3,370.00 Cr. |
Time | ALEMBICLTD | VS | Industry |
---|---|---|---|
1 Day | -0.43% | -0.11% | |
1 Week | 5.04% | 2.94% | |
1 Month | 4.98% | 1.03% | |
6 Months | 1.09% | 22.15% | |
1 Year | 1.09% | 48.03% |
Period (Days) | SMA | Indication |
---|---|---|
10 | 129.25 | Bullish |
20 | 130.62 | Bullish |
30 | 128.56 | Bullish |
50 | 132.74 | Bullish |
100 | 141.11 | Bearish |
200 | 119.62 | Bullish |
Annual | FY 2024 | FY 2023 | FY 2022 | ||||
---|---|---|---|---|---|---|---|
Operating Activities | 22.69 | 38.85 | -17.75 | ||||
Investing Activities | 25.84 | 7.30 | 18.85 | ||||
Financing Activities | -48.19 | -46.39 | -5.82 | ||||
Net Cash Flow | 0.33 | -0.24 | -4.72 |
All Figures in ₹ Cr., unless mentioned otherwise
Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
---|---|---|---|---|---|
Alembic | -0.43 | 5.04 | 4.98 | 1.09 | 1.09 |
Advanced Enzyme Tech | -0.37 | -1.98 | -21.92 | 0.33 | 11.9 |
Aster DM Healthcare | -2.89 | 9.97 | 7.13 | 26.04 | 40 |
Divi's Laboratories | -0.98 | 1.75 | 4.98 | 36.98 | 63.45 |
Alembic Pharmaceuticals | 0.3 | 0.94 | -3.24 | 12.35 | 55.36 |
Alembic Limited is an Indian company that develops, manufactures and markets pharmaceutical products such as dosage forms and active ingredients. The company operates through one segment, Pharmaceuticals. The Pharmaceutical segment manufactures and markets fermentation and chemical-based active ingredients (API). The company also conducts R&D in Vadodara. The company manufactures/provides three main products/services: Azithromycin, Venlafaxine and Telmisartan.